Commitment COM-033
Post-approval commitment for CDSCO-2022-0033. Category: Risk Management. Priority: low.
Commitment ID
COM-033
Application
Authority
Central Drugs Standard Control Organisation
Category
Risk Management
Priority
low
Status
Overdue
Due Date
2025-08-07
Completed At
—
Owner
James O'Brien
Created
2023-01-03
Description
Provide carcinogenicity study report for 2-year rat study
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.